Kidney stones are one of the most common urological diseases worldwide and represent a growing burden on healthcare systems. Traditional diagnostic procedures and therapeutic approaches, from imaging and drug-based stone dissolution to invasive surgical methods, are fraught with limitations. Nanomedicine opens up new perspectives here: Nanomaterials enable more precise early detection, improve imaging, have antioxidant and antibacterial effects, transport drugs in a more targeted manner and can even control biofilm-associated infections. The following article presents the latest advances in this field and discusses the clinical relevance for nephrologists.
You May Also Like
- Clinical case reports and implications for GP care
Magnesium deficiency and dilated cardiomyopathy in the peripartum context
- SID Annual Meeting: Highlights
Update on inflammatory dermatoses – a concentrated load of innovative power
- Case series
Bleeding prophylaxis for von Willebrand disease
- A critical analysis of the evidence from 113 studies
Nutrition and depression
- An emerging interface with clinical relevance
Lung cancer and neuroscience
- Acute leukemia: Disease management
Priorities from the perspective of patients and family caregivers
- Bronchodilators for asthma
The early bird … gasps for air
- Chronic kidney disease (CKD)